BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 33212091)

  • 1. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay.
    Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA
    J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes.
    Herzig MC; Christy BA; Montgomery RK; Cantu-Garza C; Barrera GD; Lee JH; Mucha N; Talackine JR; Abaasah IA; Bynum JA; Cap AP
    Front Immunol; 2023; 14():1225047. PubMed ID: 37822938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro.
    Conforti A; Scarsella M; Starc N; Giorda E; Biagini S; Proia A; Carsetti R; Locatelli F; Bernardo ME
    Stem Cells Dev; 2014 Nov; 23(21):2591-9. PubMed ID: 24937591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord-derived mesenchymal stem cells suppress proliferation of PHA-activated lymphocytes in vitro by inducing CD4(+)CD25(high)CD45RA(+) regulatory T cell production and modulating cytokine secretion.
    Yang H; Sun J; Li Y; Duan WM; Bi J; Qu T
    Cell Immunol; 2016 Apr; 302():26-31. PubMed ID: 26774852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes.
    Ranera B; Antczak D; Miller D; Doroshenkova T; Ryan A; McIlwraith CW; Barry F
    Equine Vet J; 2016 Mar; 48(2):253-60. PubMed ID: 25582202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire.
    Davies LC; Queckbörner S; Jylhä CE; Andrén AT; Forshell TZP; Blanc KL
    Cytotherapy; 2023 Sep; 25(9):956-966. PubMed ID: 37354149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopreservation of peripheral blood mononuclear cells for use in proliferation assays: First step towards potency assays.
    Juhl M; Christensen JP; Pedersen AE; Kastrup J; Ekblond A
    J Immunol Methods; 2021 Jan; 488():112897. PubMed ID: 33049298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.
    Chinnadurai R; Copland IB; Garcia MA; Petersen CT; Lewis CN; Waller EK; Kirk AD; Galipeau J
    Stem Cells; 2016 Sep; 34(9):2429-42. PubMed ID: 27299362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs.
    Remacha AR; Barrachina L; Álvarez-Arguedas S; Ranera B; Romero A; Vázquez FJ; Zaragoza P; Yañez R; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2015 Jun; 165(3-4):107-18. PubMed ID: 25977164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis.
    Zhang Z; Ding Y; Li W; Song B; Yang R
    Arthritis Res Ther; 2013 Oct; 15(5):R169. PubMed ID: 24286220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem/stromal cell quality control: validation of mixed lymphocyte reaction assay using flow cytometry according to ICH Q2(R1).
    Nicotra T; Desnos A; Halimi J; Antonot H; Reppel L; Belmas T; Freton A; Stranieri F; Mebarki M; Larghero J; Cras A; Faivre L
    Stem Cell Res Ther; 2020 Oct; 11(1):426. PubMed ID: 33004063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells do not suppress lymphoblastic leukemic cell line proliferation.
    Mousavi Niri N; Jaberipour M; Razmkhah M; Ghaderi A; Habibagahi M
    Iran J Immunol; 2009 Dec; 6(4):186-94. PubMed ID: 20054106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune modulation via adipose derived Mesenchymal Stem cells is driven by donor sex in vitro.
    Mckinnirey F; Herbert B; Vesey G; McCracken S
    Sci Rep; 2021 Jun; 11(1):12454. PubMed ID: 34127731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.
    Zhou C; Yang B; Tian Y; Jiao H; Zheng W; Wang J; Guan F
    Cell Immunol; 2011; 272(1):33-8. PubMed ID: 22004796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease.
    Amorim RM; Clark KC; Walker NJ; Kumar P; Herout K; Borjesson DL; Wang A
    Stem Cell Res Ther; 2020 Jul; 11(1):304. PubMed ID: 32698861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro.
    Paterson YZ; Rash N; Garvican ER; Paillot R; Guest DJ
    Stem Cell Res Ther; 2014 Jul; 5(4):90. PubMed ID: 25080326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.